Anterior segment dysgenesis (ASD) disorders encompass a spectrum of developmental conditions affecting the cornea, iris, and lens and are generally associated with an approximate 50% risk for glaucoma. These conditions are characterized by both autosomal dominant and recessive patterns of inheritance often with incomplete penetrance/variable expressivity. This article summarizes what is known about the genetics of ASD disorders and reviews recent developments.
Introduction
Anterior segment dysgenesis (ASD) disorders encompass a wide variety of developmental conditions affecting the cornea, iris, and lens. Congenital anomalies typically include, alone or in combination, corneal opacity, posterior embryotoxon, iris hypoplasia, corectopia or polycoria, and adhesions between the iris and cornea or lens and cornea. Some specific combinations have been recognized as separate diagnostic entities: Axenfeld-Rieger anomaly (ARA) is the term given to the combination of iris hypoplasia, posterior embryotoxon, iris hypoplasia, corectopia/polycoria, and/or irido-corneal adhesions, whereas Peters anomaly is used to refer to the triad of corneal opacity, defects in the posterior layers of the cornea, and lenticulo-corneal and/or irido-corneal adhesions.
Anterior segment dysgenesis can be an isolated ocular anomaly or accompanied by systemic defects. As a whole, anterior segment anomalies are associated with an approximate 50% risk of glaucoma [1, 2] . The most common syndromes associated with ASDs are Axenfeld-Rieger syndrome (ARS), characterized by ARA of the eye and systemic anomalies (typically hypo/microdontia, redundant periumbilical skin/umbilical hernia, and craniofacial dysmorphism; Fig. 1) [3 ] ; Peters Plus syndrome (PPS) that comprises anterior chamber eye defects (primarily Peters anomaly; Fig. 2 ) along with short stature, brachydactyly and/or rhizomelic shortening and variable other systemic anomalies; Alagille syndrome, characterized by the presence of posterior embryotoxon in the eye as well as characteristic facial appearance and abnormalities of the liver, heart, skeleton, and kidneys; SHORT syndrome [Short stature, Hyperextensibility of joints or inguinal Hernia, Ocular depression, Rieger eye anomaly, and delay in dental eruption (Teeth); Fig. 3 ] [4 ] ; and Pierson syndrome, also called microcoria-congenital nephrosis syndrome. Our review will focus on genes with new reports published within the past 2 years.
see Table 1 for details of identified genes and associated phenotypes [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . PAX6 The first gene discovered to play a role in human anterior segment disorders was PAX6 [5, 6] . The spectrum of PAX6 mutations and associated phenotypes has been extensively reviewed in several previous publications ( [21, 22, 23 ] . The majority of PAX6 mutations are nonsense, splicing, insertions, and deletions, and the most common associated phenotype is aniridia, with or without other ocular anomalies ( [21, 22, 23 ] . A few missense mutations have been reported that typically result in milder ocular phenotypes without aniridia including Peters anomaly, uveal ectropion, ectopia pupillae, cataracts, vascularized cornea (autosomal dominant kertatitis), elliptical anterior iris stromal defects and iris hypoplasia Genetics of anterior segment dysgenesis disorders Reis and Semina 315
Key points
Anterior segment dysgenesis disorders demonstrate different modes of inheritance and a high degree of inter and intrafamilial phenotypic variability. Molecular genetic analysis and examination of family members can assist in providing accurate genetic counseling. A significant overlap among phenotypes attributed to mutations in different anterior segment dysgenesis (ASD) genes is well recognized. Functional studies have suggested that several of the ASD causative genes may function within a common pathway. Identification of deletions downstream of PAX6 and upstream of PITX2 highlight the importance of regulatory region mutations in human ocular disease and suggest that aCGH data should be analyzed for possible deletions of upstream and downstream regions of other genes. [ [24] [25] [26] [27] . Whereas PAX6 deletion was reported in one case of ARS with ocular and systemic anomalies [28] , this association was recently rescinded. The authors reported subsequent testing showed normal PAX6 copy number and identification of a PITX2 mutation (c.253-11A>G) in the original patient [29] .
Interestingly, several groups have reported deletions of the downstream regulatory region of PAX6 which leave the coding region intact yet result in an aniridia phenotype [30] [31] [32] [33] . Array-based comparative genomic hybridization (aCGH) has recently identified deletions downstream of PAX6 in three additional families and multiplex ligation-dependent probe amplification (MLPA) analysis identified a fourth. These deletions resulted in aniridia in three families [34,35 ,36 ] and atypical aniridia which was initially diagnosed as ARA in the other [37 ] . These new reports confirm the importance of the 3' regulatory region and provide further evidence of disease causing mutations outside the coding region of a gene.
Several recent publications have focused on the role of PAX6 in the developing brain, reporting mutations associated with absence of the pineal gland and interhemispheric brain anomalies 
JAG1
Alagille syndrome, a highly variable developmental disorder involving liver, heart, ocular, and vertebral anomalies along with characteristic facial features, is associated with mutations in or deletions of the JAG1 gene [7, 8] . Bile duct paucity, chronic cholestasis, heart murmur due to pulmon-ary stenosis or structural intracardiac disease, and characteristic facial features are seen in almost all affected individuals [45] . Butterfly vertebrae and kidney disease are also commonly seen [45] . Ocular anomalies are seen in 78-95% of patients, primarily posterior embryotoxon, although other ASDs such as iris hypoplasia and small corneal diameters are also common and irido-corneal synechiae and corectopia have been occasionally reported [45] [46] [47] . Abnormalities affecting the posterior segment of the eye are also seen in most patients, including pigmentary retinopathy, abnormal retinal vessels, and optic disc anomalies, particularly optic disc drusen [46, 47] .
PITX2 and FOXC1
Both PITX2 [9] and FOXC1 [10, 11] disruption via intragenic mutation or deletion are associated with ARA with 316 Ocular genetics or without systemic anomalies. The spectrum of phenotypes associated with mutations in these genes was recently reviewed [48] . Whereas other phenotypes including Peters anomaly (PITX2 and FOXC1), isolated iris hypoplasia/iridogoniodysgenesis (PITX2 and FOXC1), ring dermoid of the cornea (PITX2), primary congenital glaucoma (FOXC1), and aniridia (FOXC1) have been associated with mutations in these genes, PITX2 disruption is primarily associated with ARS with typical ocular anomaly accompanied by dental and umbilical defects and FOXC1 disruption primarily results in ARS with heart or hearing defects or an isolated ocular phenotype [48] . Duplication of FOXC1 also results in ASD including iris hypoplasia with glaucoma [49, 50] , microcornea [51] , Peters anomaly [52] , and iridogoniodysgenesis [53] .
A recent screening of 80 probands with ASD with or without systemic anomalies provided the first thorough screening of PITX2 and FOXC1 for both nucleotide mutations and copy number changes. Intragenic mutations or deletions were detected in 32 (40%) [54 ] . Eleven of the 13 probands with PITX2 disruption had ocular, dental and umbilical anomalies, one had ocular and dental anomalies with umbilicus not examined, and no details were available for the final case [54 ] . Details regarding systemic features was provided for 14 of the 19 probands with FOXC1 disruption: 6 had isolated ocular (with minor craniofacial features in 3), 6 had ocular and hearing loss (with dental anomalies in 4), and 2 had ocular and dental anomalies with normal hearing [54 ] .
Similar to PAX6, aCGH identified deletion of an upstream regulatory region of PITX2 in a patient with ARS ( Fig. 1 ) [3 ] . Array CGH also identified a deletion of FOXC1 in an infant with partial aniridia, congenital glaucoma, heart defect, and bilateral club feet [37 ] .
Two additional studies presented new cases of intragenic PITX2 mutations: a novel missense mutation was reported in a patient with Peters anomaly, persistent ocular fetal vasculature, and unilateral microphthalmia [55 ] . A previously reported missense mutation was identified in a three-generation pedigree with ocular, umbilical, dental, and craniofacial features in affected family members [56 ] . These studies further highlight the variable expressivity of PITX2 mutations, including both ocular and craniofacial features.
FOXC2
Ocular examination of patients with lymphedemadistichiasis syndrome and mutations in FOXC2, another member of the forkhead family, identified mild ASD, including partial iris hypoplasia, corectopia, reduced corneal diameter, and localized corneal opacification, in those with mutations within the forkhead domain [12] . No subsequent studies have investigated the role of FOXC2 in anterior segment dysgenesis.
PITX3
Heterozygous mutations in PITX3, another member of the PITX family, have been reported in 11 families with congenital posterior polar cataract with ASD in some individuals [13, [57] [58] [59] [60] [61] . The most common mutation is a recurrent 17-bp insertion (c.657_673dup17) in the C-terminal region seen in all but three families. In one family, two individuals inherited homozygous PITX3 mutations resulting in bilateral microphthalmia, corneal opacification, and severe developmental delay [60] . The paucity of reported cases as well as two recent studies reporting a lack of mutation in 27 probands with isolated congenital cataract [43 ] and a large family with autosomal recessive history of cataract and mental retardation [62 ] and the role of PITX3 in human disease [63 ] . New investigations suggest that PITX3 may play a role in Parkinson's disease as well [64, 65 ] .
FOXE3
Whereas homozygous/compound heterozygous mutations in FOXE3 result in microphthalmia with primary aphakia/sclerocornea, heterozygous mutations have been reported in six families with ASD with or without cataract [14,43 ,66,67,68 ] . The first mutation identified and three subsequent heterozygous mutations disrupt the distal part of the gene (three in stop codon 320 and one in residue 315) and result in extension of the FOXE3 protein with the addition of 72-117 erroneous amino acids [14,43 ,67,68 ] . These mutations primarily resulted in anterior segment dysgenesis with cataract, one proband demonstrated colobomatous microphthalmia in addition to ASD, and one had isolated congenital cataract. The first missense mutation, p.R90L in the DNA-binding domain, resulted in familial Peters anomaly with or without cataract [66] . A second missense mutation, p.G49A, was reported in a proband with microphthalmia/coloboma and family members with cataract [67] ; although, a more recent study suggested that p.G49A may be a polymorphic variant as it was seen in 3% of African-American controls [69] . Interestingly, carrier relatives of individuals with homozygous/compound heterozygous FOXE3 mutations are almost universally unaffected [67, [69] [70] [71] [72] , suggesting an alternate mechanism for mutations which result in dominant versus recessive disease. The possibility of a dominantnegative mechanism for heterozygous mutations has been raised, but one group recently challenged this hypothesis [68 ] .
BMP4 and BMP7
Disruption of BMP4 by deletion or mutation is associated with ocular, digit (polydactyly), brain/neurological (abnormal structure, hypotonia/delay) and craniofacial (dysmorphic facial features, macrocephaly) anomalies as well as poor growth [4 ,15] . Whereas most individuals with BMP4 disruption exhibit clinical anophthalmia/ microphthalmia with or without ASD [4 ,15] , anterior segment anomalies with normal eye size have also been reported [73] . Most recently, a patient with SHORT syndrome was found to have a 2.3-Mb deletion of BMP4 and 13 other genes [4 ] ; ocular features included ARA, congenital glaucoma and microcornea ( Fig. 3 ).
Another member of the BMP family, BMP7, has been recently evaluated in patients with anophthalmia, microphthalmia, and coloboma with mutations not seen in controls (but inherited from unaffected or mildly affected mothers) identified in two patients with anophthalmia and systemic defects [74 ] . Screening of patients with ASD phenotypes is indicated to determine whether or not this gene plays a role in other ocular disorders since, similar to Bmp4, Bmp7 has also been implicated in the development of anterior segment structures in mice [75] .
COL4A1
One of the most recently reported genes associated with ASD is COL4A1, which encodes a collagen chain important in the formation of basement membranes. Mouse Col4a1 is expressed in the anterior segment of the eye [76] . Mutations in COL4A1 were initially identified as a cause of porencephaly and brain small vessel disease with stroke and retinal arteriolar tortuosity in some individuals [16, 17] and then also found to be associated with anterior segment ocular anomalies ( Table 2) including early-onset cataract [77] [78] [79] , ARA, corneal opacities, congenital cataract, microcornea, elevated intraocular pressure, and/or glaucoma [80, 81 ] . The range of neurological features was recently reviewed [82 ] . Brain MRI often reveals anomalies in mutation carriers even in the absence of neurological symptoms.
Autosomal recessive anterior segment dysgeneses
Other identified loci are mainly associated with autosomal recessive inheritance of ocular disease (Table 1) .
CYP1B1
Homozygous/compound heterozygous mutations in CYP1B1 are typically associated with primary congenital glaucoma [18] . Several studies have identified mutations in patients with isolated Peters or ARA, typically in association with glaucoma [83] [84] [85] [86] . Three out of 11 patients with anterior segment defects had only a single heterozygous mutation identified, suggesting that there may be a second mutation in a CYP1B1 regulatory region that is yet to be identified, or a mutation in a second gene which contributes to the phenotype, as has been reported for CYP1B1 and MYOC in primary congenital and juvenile onset glaucoma [87] [88] [89] .
Two novel anterior segment phenotypes were recently linked to CYP1B1 mutations. Compound heterozygous CYP1B1 mutations were identified in a patient with ARS including protruding umbilicus and malaligned teeth [90 ] . This is the first association of CYP1B1 with the systemic features of ARS. Homozygous or compound heterozygous mutations were identified in eight probands with mild ectropion uveae, partial aniridia, and congenital glaucoma [91 ] , further expanding the ocular phenotype associated with CYP1B1 mutations.
LAMB2
Mutations in LAMB2 result in Pierson syndrome, characterized by congenital nephrotic syndrome and ocular defects along with neurologic anomalies in some [19] . The primary ocular feature is miosis. Other eye defects that are occasionally observed include iris hypoplasia, ectropion uveae, microcornea, glaucoma, cataract, posterior embryotoxon, microphthalmia, posterior lenticonus, microspherophakia, cloudy or enlarged corneas, and generalized anterior segment dysgenesis [92] . The full spectrum of mutations and associated phenotypes was recently reviewed [93 ] . The majority of mutations are truncating; whereas missense mutations are typically associated with later onset of renal disease and lack of neurologic abnormalities, phenotypic variability is not perfectly correlated to LAMB2 genotype. Recently, the first two Asian patients with two truncating mutations have been reported with typical ocular findings but milder renal involvement, suggesting that race may play a role in phenotypic variability [94 ,95] . Finally, a novel homozygous missense mutation was seen in nine members of a Mennonite family affected with a variant phenotype consisting of infantile nephrotic syndrome, chorioretinal pigmentary changes, and retinal detachments in some individuals, but no microcoria or neurologic anomalies [96 ] . Results from a screening of 30 patients suggested that LAMB2 mutations explain all cases of typical Pierson syndrome [93 ] .
B3GALTL
Peters Plus syndrome is a rare congenital disorder characterized by anterior chamber eye defects (primarily Peters anomaly) and variable systemic anomalies primarily including short stature, brachydactyly and/or rhizomelic shortening, developmental delay, dysmorphic facial features, cleft lip and/or palate, and heart, genitourinary, or ear anomalies [97] . The role of B3GALTL in PPS was recently identified with splicing mutations/deletions identified in 20 of 20 patients [20] , including a recurrent c.660þ1G>A mutation. Subsequent screens revealed mutations/ deletions in nine additional patients with typical PPS [98] [99] [100] [101] 102 ] ; splicing mutations are the most commonly seen. Review of these previous studies suggests that the presence of ASD, short stature, brachydactyly, and characteristic facial features is predictive of B3GALTL mutations, whereas no mutations in B3GALTL were identified in eight patients with atypical PPS (some but not all of these typical features) (Table 3 ) [99, 101, 104 ] . However, recent screening of B3GALTL in two siblings whose phenotype closely matched PPS failed to identify mutations: the siblings were affected with bilateral corneal opacity, small hands/feet, short stature, and similar facial features along with growth hormone deficiency and hypoplastic pituitary gland in one (Table 3 ) [103] .
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Conditions and genes occasionally associated with anterior segment dysgenesis
Oculo-dental-digital dysplasia, affecting the eye, dentition, digits of the hands and toes, with facial features, and neurological and hearing deficits, is caused by mutations in the GJA1 gene [105] . Whereas microphthalmia and microcornea are the primary ocular phenotype, increased risk of glaucoma is also seen and a proportion of patients have iris anomalies [106] . Mutations in SOX2 are primarily associated with SOX2 Anophthalmia syndrome characterized by clinical anophthalmia/microphthalmia and variable brain, pituitary, genitourinary, and gastroesophageal defects [107, 108] . One individual with isolated iris hypoplasia and a family member with isolated microcornea were reported with a missense mutation in SOX2 [109] . Subsequent screening of 28 probands with various ASDs failed to identify any mutations in SOX2 [110 ] .
Anterior segment anomalies were first reported with mutations in FGFR2 in three patients with Pfeiffer or Crouzon syndrome (craniosynostosis syndromes), including two with Peters anomaly [111] . In another family, the proband was affected with ARA and right microcornea along with premature fusion of the sagittal suture. His mother carried the same FGFR2 mutation and was found to have mild iris hypoplasia and posterior embryotoxon with mild exorbitism but no craniosynostosis [112] . Most recently, corectopia, limbal scleralization, microcornea, and glaucoma were reported in a patient with Pfeiffer syndrome [113 ] .
Novel genomic regions associated with anterior segment dysgenesis
Several new cases of chromosomal anomalies associated with ASD have been reported. Linkage to chromosome 2 was identified in a large family affected with microcornea, atypical iris coloboma, congenital cataract, and microphthalmia [114] . A proband with ARA, global delay, dysmorphic features, and retinoblastoma was found to have del(13)(q12;q22) including the RB1 gene at 13q14 [115 ] and overlapping the 13q deletions reported in two previous cases of ARA, one of whom also exhibited retinoblastoma and severe developmental delay [116, 117] . A complex chromosomal rearrangement, inv(2)(p22.3q12.1)t(2;16)(q12.1;q12.2), was detected in another patient with aniridia, aphakia, corneal anomalies, and congenital glaucoma. The authors hypothesized that the separation of the IRXB gene cluster from its regulatory region at 16q12.2 is the cause of the observed anterior segment dysgenesis [118 ] . Finally, aCGH identified a 326-kb deletion at 9p22.31 in a patient with an atypical PPS phenotype consisting of unilateral Peters anomaly and microphthalmia, intrauterine growth retardation, clinodactyly, dsymorphic facial features, 320 Ocular genetics Dassie-Ajdid et al. agenesis of the right lung, and heart, gastrointestinal, and genitourinary defects [119] . This deletion encompasses 8 of the 9 exons of the ROR2 gene, previously associated with an autosomal recessive form of Robinow syndrome, a condition that sometimes involves infantile glaucoma (Dr Alex Levin, personal communication).
Conclusion
Identification of the genetic cause of ASDs has revealed multiple genetic loci. Whereas the primary phenotype associated with ASD genes is typically distinct, most genes are involved in multiple related ASD phenotypes with a high degree of inter and intrafamilial variable phenotypic expressivity. Novel technologies including whole genome/exome sequencing and aCGH have greatly facilitated identification of the genetic cause of these conditions [120 ] and are likely to broaden the spectrum of mutations associated with known ASD genes as well as to assist in identification of new causative and modifier loci. Array CGH has identified several deletions of regulatory regions in ASDs, highlighting a novel disease mechanism. Genetic interactions between known factors are beginning to be elucidated and are likely to provide insight into the basis of the extreme variability of what are currently known as single-gene conditions.
